Fig. 4From: Identification of the principal neuropeptide MIP and its action pathway in larval settlement of the echiuran worm Urechis unicinctusCRE-driven luciferase activity in HEK293T cells treated by MIP2. 1: the Forskolin treatment group with 10 µM; 2–5: MIP2 treatment group with 10, 100, 1000, 10,000 nM + 10 µM Forskolin, respectively. Each rhombus represents a data. Different letters indicate significant differences (p < 0.05)Back to article page